ISI. Made Sukada

I. Made Sukada

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


I. Made Sukada has a total of 27 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Hematological Profile of Healthy White-Bellied Sea Eagles (Haliaeetus leucogaster) Undergoing Rehabilitation at Bali Wildlife Rescue Centre

    by Nathania Viany, Theresia Kintan Putri Kinanti, Jeanette Chandra, Devana Xaviera Mulholland, Tjok Gde Oka Pemayun, I Wayan Sudira, I Made Sukada, Nyoman Sadra Dharmawan

    Background: Haliaeetus leucogaster, or the white-bellied sea eagle, is one of the largest raptors in Indonesia and plays a crucial role in maintaining ecological balance. Hematological evaluation is essential for assessing health and release suitability after rehabilitation; however, reference data for this species, especially from Indonesia, remain limited. Purpose: This study aimed to support clinical assessments and conservation strategies by, providing descriptive hematological data for H. leucogaster undergoing rehabilitation at the Bali Wildlife Rescue Centre, Indonesia. Method: Blood samples from five healthy H. leucogaster were analyzed at the Udayana University Veterinary Teaching Hospital. Measurements included erythrocyte and leukocyte counts, hematocrit, hemoglobin, erythrocyte indices (MCV, MCH, MCHC), and differential leukocyte counts. Morphology was documented using Optilab Viewer 2.2. Morphometry was measured using Image Raster 3. Data are presented as mean ± SD and range. Results: Mean erythrocyte count was 2.95±0.41×106/µL, hematocrit 48.80±5.60%, hemoglobin 10.54±1.29 g/dL, MCV 171.06±36.62 fL, MCH 37.41±10.14 pg, and MCHC 21.84±3.38 g/dL. Mean leukocyte count was 13.69±4.31×103/µL, with heterophil predominance (56.8±3.42%). Erythrocyte and leukocyte morphology and morphometry were consistent with normal avian raptor references. Monocytes were the largest leukocytes (13.09±0.86×12.19±1.08 µm, perimeter 41.13±2.33 µm) and basophils were the smallest (6.10±0.76×5.46±0.68 µm, perimeter 19.31±2.60 µm). Conclusion: Hematological values for H. leucogaster at the Bali Wildlife Rescue Centre fall within published references and provide preliminary data for individuals undergoing rehabilitation in Indonesia. These findings may assist veterinarians and rehabilitators in evaluating health status during rehabilitation and prior to release.

  • Antimicrobial Resistance in Catfish Aquaculture in Indonesia: Antibiotic Use, Resistance Genes, and One Health Risks

    by Kadek Karang Agustina, I Made Sukada, Ida Bagus Krisna Pradnyadana, Putu Arya Duta Adnyana, Ni Putu Dewi Setia Sari, Ni Ketut Harmini Saraswati, Ida Bagus Kade Suardana

    Catfish (Clarias spp.) aquaculture plays a crucial role in food security and rural livelihoods in Indonesia. Inappropriate antimicrobial use (AMU) can increase antimicrobial resistance (AMR), posing risks to aquaculture, environmental health, and food safety. The present study aimed to review AMR associated with catfish aquaculture in Indonesia within a One Health framework. A review was carried out according to structured literature review guidelines. Relevant peer-reviewed articles published between 2020 and 2026 were found in Scopus, Web of Science, PubMed, ScienceDirect, and Google Scholar. The searches employed specific combinations of keywords concerning catfish aquaculture, antimicrobial usage, antimicrobial resistance, and Indonesia. Data on AMU, resistant bacteria, antimicrobial-resistance genes (ARGs), and antibiotic residues were extracted from the included studies and categorized into these four subjects descriptively. Findings across studies were compared to identify commonly reported antimicrobials, patterns of bacterial resistance, detected ARGs, and the occurrence of antibiotic residues. Due to differences in study designs, sampling methods, bacterial species, and antimicrobial susceptibility testing methods, the findings were synthesized narratively rather than pooled statistically. The current findings indicated that oxytetracycline, tetracycline, and enrofloxacin were the most commonly used antibiotics. Resistant bacteria, particularly Aeromonas hydrophila, frequently exhibited resistance to tetracycline, oxytetracycline, ampicillin, and amoxicillin. Other pathogens, including Edwardsiella tarda and Proteus spp., also demonstrated multidrug resistance to tetracycline, oxytetracycline, ampicillin, and amoxicillin. The ARGs such as tetA, tetE, qnrA, qnrB, qnrS, ampC, blaGES, and mexF were detected in bacterial isolates and aquaculture environments. Antibiotic residues, including fluoroquinolones, sulphonamides, chloramphenicol, and tetracycline, were detected in aquatic environments and catfish products. Oxytetracycline residues ranging from 0.14 to 0.90 mg/kg were detected in catfish meat, with 25% of 59 samples exceeding the reported maximum residue limits. The current findings suggested that catfish aquaculture in Indonesia may contribute to the emergence and spread of AMR. The co-occurrence of antibiotic use, resistant bacteria, ARGs, and environmental contamination highlighted the need for strengthened antimicrobial stewardship, surveillance, and integrated disease management under a One Health approach.

  • Open Access

    Pathogenesis studies of African swine fever virus isolates from Bali and East Nusa Tenggara as a basis for inactivated vaccine development

    by I Wayan Masa Tenaya, Kadek Karang Agustina, Ketut Suada, Made Sukada, Romy Muhammad Dary Mufa, Ida Ayu Pasti Apsari, I Made Dwinata, Ida Bagus Komang Ardana, Made Damriyasa, Tri Komala Sari, et al.

    African swine fever (ASF) is a highly contagious and lethal disease of pigs for which no effective vaccine is currently available. This study evaluated the pathogenicity of field African swine fever virus (ASFV) isolates from Bali and East Nusa Tenggara and assessed their potential for inactivated vaccine development using spleen-derived antigens. Based on the qPCR results, among all ASFV isolates tested, only the Bali isolate, designated B1, exhibited the highest DNA concentration, suggesting that this sample contained the highest ASFV titer. Consequently, the B1 isolate was selected and processed into chemically treated (CT-ASFV) and non-treated (NCT-ASFV) formulations. In the pathogenesis trials, pigs inoculated with NCT-ASFV developed acute ASF and died within 12 days, whereas those receiving CT-ASFV exhibited no clinical signs of ASF and showed no evidence of viral replication. In the vaccination trial, pigs immunized with CT-ASFV emulsified in Montanide™ ISA 50 V2 demonstrated survival in two out of three animals (67%) following challenge with a virulent strain, while all control animals succumbed to infection. Despite the absence of detectable humoral responses as determined by ELISA, the observed protection suggests a potential role for cell-mediated immunity. These findings indicate that the B1 isolate was highly virulent and represents a promising candidate for the development of an inactivated ASF vaccine. Further evaluation in larger-scale field trials is warranted.


  • Open Access

    Preparation of hyperimmune serum against multidrug-resistant Escherichia coli isolated from animal products in Bali and Nusa Tenggara, Indonesia: An epidemiological perspective

    by I. Wayan Masa Tenaya, Kadek Karang Agustina, I. Ketut Suada, I. Made Sukada, Romy Muhammad Dary Mufa, Ida Ayu Pasti Apsari, Tri Komala Sari, Ni Made Handayani, Hamong Suharsono

    Background and Aim: The global rise of antimicrobial resistance (AMR), particularly multidrug-resistant Escherichia coli (MDR E. coli), poses a significant threat to public health, animal health, and environmental safety. Traditional antibiotics are increasingly ineffective, necessitating alternative approaches such as immunotherapy. Hyperimmune serum represents a potential solution to combat MDR pathogens by providing immediate passive immunity. The present study aimed to produce and evaluate hyperimmune serum against MDR E. coli isolated from animal products in Bali and Nusa Tenggara, Indonesia, as a novel immunotherapeutic strategy against AMR. Materials and Methods: Five MDR E. coli isolates resistant to eight antibiotics were obtained from the Quality Testing and Certification Center for Animal Products in Bogor, Indonesia. Isolates originated from Bali, West Nusa Tenggara, and East Nusa Tenggara. Bacterial isolates were cultured in Yeast Tris (YT) broth medium supplemented with antibiotics. Bacterial proteins were extracted, solubilized, and emulsified with Freund’s complete and incomplete adjuvants. A 2-year-old horse was immunized with prepared antigens through intramuscular injections over 6 weeks, followed by intravenous administration. Serum was collected pre- and post-immunization. Confirmation of the hyperimmune serum’s specificity and neutralizing capability was performed using an in vitro agar plate test. Results: Successful growth of MDR E. coli isolates was confirmed in antibiotic-supplemented media, whereas no growth was observed in the antibiotic-sensitive native control. Hyperimmune serum obtained post-immunization exhibited strong in vitro specificity, recognized homologous MDR E. coli isolates, and formed significant neutralization zones (5–6 mm) around agar diffusion disks. Pre-immunization serum showed no reactivity, demonstrating effective production of specific antibodies. The neutralization zones were slightly smaller than those achieved with chloramphenicol control, indicating effective but slightly reduced bactericidal activity. Conclusion: The study successfully demonstrated that hyperimmune serum generated from MDR E. coli isolates from animal products has specific neutralizing activity against homologous MDR bacterial strains. These findings support the potential application of hyperimmune sera as an immunotherapeutic tool to mitigate AMR-related infections. Further research is necessary to standardize Immunoglobulin G concentrations, determine optimal immunization protocols, and evaluate clinical efficacy in vivo. The hyperimmune serum preparation represents a promising advancement for tackling MDR bacterial infections and contributes substantially to One Health strategies aimed at reducing the public health threat posed by AMR. Keywords: antimicrobial resistance, hyperimmune serum, immunotherapy, multidrug-resistant Escherichia coli, One Health.